The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Acute kidney injury 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Capillary leak syndrome 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Diarrhoea 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Disease progression 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Nausea 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Nephrogenic diabetes insipidus 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Pulmonary oedema 1
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Temperature intolerance 1
OXALIPLATIN MYLAN Neutropenia 1
OXALIPLATIN MYLAN Pyrexia 1
OXALIPLATIN Pliva Defaecation urgency 1
OXALIPLATIN Pliva Nausea 1
OXALIPLATIN Pliva Paraesthesia 1
OXALIPLATIN Pliva Tongue disorder 1
OXALIPLATIN Pliva Vomiting 1
OXALIPLATIN SANDOZ Autoimmune disorder 1
OXALIPLATIN SANDOZ Diarrhoea 1
OXALIPLATIN SANDOZ Electrolyte imbalance 1
OXALIPLATIN SANDOZ Haemoptysis 1
OXALIPLATIN SANDOZ Hypotension 1

Total Records: 864     Number of Pages: 44